CompletedPhase 3NCT00381147
Use of Clarithromycin in Mustard-Induced Bronchiolitis
Studying Bronchiolitis obliterans
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baqiyatallah Medical Sciences University
- Principal Investigator
- Mostafa Ghanei, ProfessorResearch Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
- Intervention
- Clarithromycin(drug)
- Eligibility
- MALE
Study locations (1)
- Baqiyatallah Medical Sciences University, Tehran, Tehran Province, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00381147 on ClinicalTrials.govOther trials for Bronchiolitis obliterans
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07535008Dental Cleaning to Prevent Chronic Graft-Versus-Host DiseaseFred Hutchinson Cancer Center
- RECRUITINGNCT07522008ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic SymptomsAzienda Ospedaliera Brotzu
- RECRUITINGEARLY PHASE1NCT07239895Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem CellsRegend Therapeutics
- RECRUITINGPHASE4NCT07045155Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term DialysisChinese PLA General Hospital
- RECRUITINGNANCT07008170Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct StonesMinia University
- RECRUITINGNANCT07002944Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder PainCairo University
- ACTIVE NOT RECRUITINGNCT07316829TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSFondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGPHASE2NCT06476132Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant RecipientsNational Institute of Allergy and Infectious Diseases (NIAID)